Filtros : "Financiamento Sichuan Science and Technology Program" "Financiamento Sichuan Provincial Administration of Traditional Chinese Medicine" Limpar

Filtros



Limitar por data


  • Fonte: MedComm. Unidade: IQ

    Assuntos: RECEPTORES, ADENOSINA, TRANSTORNOS COGNITIVOS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, v. 6, p. 1-23 art. e70177, 2025Tradução . . Disponível em: https://dx.doi.org/10.1002/mco2.70177. Acesso em: 16 nov. 2025.
    • APA

      Illes, P., Rubini, P., Ulrich, H., Yin, H. -Y., & Tang, Y. (2025). Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, 6, 1-23 art. e70177. doi:10.1002/mco2.70177
    • NLM

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.1002/mco2.70177
    • Vancouver

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.1002/mco2.70177
  • Fonte: Frontiers Pharmacology. Unidade: IQ

    Assuntos: SISTEMA NERVOSO CENTRAL, DOENÇAS DO SISTEMA NERVOSO

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 16 nov. 2025. , 2024
    • APA

      Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286
    • NLM

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
    • Vancouver

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025